28:28

WELCOME TO FUTURES 2025

01:06:53

FUTURES 2025: Care in the Context of Different Therapeutic Options & Clinical Trials

50:40

FUTURES 2025 Breakout Session: Palliative Care - Supporting the Whole Journey

01:25:20

FUTURES 2025 Breakout Session: New Therapeutic Approaches

56:18

FUTURES 2025 Therapies to Preserve and Protect Muscle

01:14:28

FUTURES 2025 Breakout Session: Managing Emergencies

27:09

Overview of Therapeutic Landscape for Duchenne

01:15:37

Champions FUTURES 2025

35:01

FUTURES 2025: Reflecting on The Remarkable Life of Ibelin

01:33:21

FUTURES 2026 Breakout Session: Exon Skipping Therapies

49:22

Thriving with Duchenne

01:26:01

Micro dystrophin Gene Therapies and BREAKING NEWS

35:20

Wave Life Sciences: Update on 48-week Data from FORWARD-53 Study

58:36

Dyne Therapeutics: The clinical impact of the FORCE™ platform

01:31

2025 Napa in Newport

12:11

Edgewise Cure Duchenne Workshop Presentation 2 26 25

11:16

2024 Cure Duchenne FUTURES Time Capsule

01:05:11

In Person Workshop Preview Webinar

01:59

2024 Getzlaf Golf Shootout

47:10

REGENXBIO Webinar

02:57

Mats Steen Legacy

04:09

What Will Your Legacy Be?

29:34

CureDuchenne Webinar with Wave Life Sciences | Interim Results

44:01

CIFFREO Data Discussion – 10 OCT 2024 EM USA DMD 0099

11:00

ITFTherapeutics 102024

10:58

Edgewise Community Presentation October 2024

20:13

CureDuchenne LINK X PicnicHealth Webchat

10:14

Edgewise Community Presentation

01:24:53

2024 FUTURES Exon skipping

44:06

Avidity Biosciences: Presentation and discussion on initial data from EXPLORE44 Clinical Trial

14:06

Navigating Duchenne treatment: AGAMREE & Catalyst Pathways

58:23

Dyne Therapeutics DELIVER trial of DYNE-251 in Duchenne

24:35

ITF THERAPEUTICS| DUVYZAT Update

01:38

The 2024 CureDuchenne FUTURES National Conference

51:48

Seminario Web Cure Duchenne: Explicación de la Decisión de la FDA acerca de Elevidys

49:42

FDA Decision on Sarepta's ELEVIDYS Webinar

01:13

Napa in Newport 2024

36:29

2024 FUTURES New Therapeutic Approaches to Address Unmet Needs

01:01:11

2024 FUTURES Preparing for the Unexpected, Responding to Emergencies

59:34

2024 FUTURES Multidisciplinary Proactive Care in Duchenne

46:05

2024 FUTURES Responding to AAV Based Treatment Challenges

53:06

KEYNOTE, Embracing OUR Future

53:37

2024 FUTURES GENE Therapy panel

30:11

2024 FUTURES - Clinical Trial Design, Lessons Learned and Implications for the Future

43:55

2024 FUTURES - Therapies to Preserve and Protect Muscle

11:37

2024 FUTURES - CureDuchenne LINK - What We Are Learning Through Your Participation

47:12

Breakout Session: 2024 FUTURES Steroid Use

34:46

2024 FUTURES Action is Therapy Getting Involved

18:05

2024 FUTURES Welcome

42:04

2024 FUTURES Keynote Peter Marks FDA

01:12

Sarepta Therapeutics le da la bienvenida a 2024 FUTURES - Un Mensaje Aspecial

00:47

Sarepta Therapeutics Welcomes You to 2024 FUTURES - A Special Message

08:12

How Exon Skipping Works

06:01

Rolling Through the Magic: Exploring Disneyland in a Power Wheelchair

01:08

Champions in Miami 2024

44:41

CureDuchenne Webinar W/ italfarmaco | Community Update with ITF Therapeutics: Introducing DUVYZAT™

01:21:52

Ask Me Anything: Traveling with Duchenne with Marissa Penrod, Adam Malone and Alan Chaulet

49:04

CureDuchenne Webinar with Dyne Therapeutics | Advancing the Promise of FORCE to Deliver for Patients

01:21:51

Pre-Recorded: Ask Me Anything: Fractures and Fatty Embolism Syndrome (FES) with Dr. Brenda Wong

15:51

WEBINAR: PTC Therapeutics – EMFLAZA® LANDSCAPE IN 2024